13F-HR filed by Blue Owl Capital Holdings LP
Blue Owl Capital Holdings LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 15:46:59 UTC, with 79 holding rows worth $547,621,681.
- Accession
- 0001193125-26-459653
- Filer
- CIK 1858703
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 79 entries on the cover page, a total value of $547,621,681 stated on the cover page (in dollars after the unit check, H1), rows summing to $547,621,681 with VALUE read as dollars as filed, 13F file number 028-21866. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBlue Owl Credit Advisors LLC
- included managerBlue Owl GPSC Advisors LLC
- included managerBlue Owl Technology Credit Advisors LLC
- included managerBlue Owl GPSC IV Advisors LLC
- included managerBlue Owl Credit Private Fund Advisors LLC
- included managerBlue Owl Healthcare Opportunities Advisors LLC
- included managerBlue Owl Alternative Credit Advisors LLC
- included managerBlue Owl Insurance Advisors LLC
- included managerBlue Owl CLO Management I LLC
- included managerBlue Owl Digital Infrastructure Advisors LLC
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP CLASS A COM STK | 84615Q103 | Stock | 923,218 | $139,276,667 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 3,343,827 | $65,104,312 | dollars as filed | |
| Latigo Biotherapeutics, Inc. | 517954103 | Common Stock, par value $0.0001 per share | 3,596,780 | $60,066,226 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 9,923,904 | $31,706,873 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 2,611,143 | $29,375,359 | dollars as filed | |
| NUVEEN CHURCHILL DIRECT LEND | 67090S108 | COM SHS | 2,143,626 | $24,094,356 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,399,899 | $21,488,450 | dollars as filed | |
| BLUE OWL CAPITAL CORPORATION COM | 69121K104 | CEF | 2,045,070 | $21,452,784 | dollars as filed | |
| Obsidian Therapeutics, Inc. | 67448A106 | Common Stock, $0.0001 par value per share | 1,482,767 | $20,358,391 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 1,125,544 | $11,120,375 | dollars as filed | |
| DELL TECHNOLOGIES INC CL C | 24703L202 | Stock | 19,342 | $10,405,029 | dollars as filed | |
| HOLLEY INC | 43538H103 | COMMON STOCK | 4,376,888 | $10,329,456 | dollars as filed | |
| CONDUENT INC | 206787103 | COM | 5,036,595 | $7,857,088 | dollars as filed | |
| DEEP FISSION INC | 243927100 | CMN | 1,333,333 | $6,839,998 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 1,390,632 | $6,438,626 | dollars as filed | |
| IMMIX BIOPHARMA INC | 45258H106 | COMMON STOCK | 602,047 | $6,264,299 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 556,371 | $5,669,420 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 45,000 | $5,455,350 | dollars as filed | |
| IMAGENEBIO INC | 45175G207 | CMN | 1,135,081 | $5,198,671 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 969,605 | $4,692,888 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 358,600 | $4,131,072 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 935,000 | $3,870,900 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 529,542 | $3,770,339 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 288,282 | $3,542,986 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 412,654 | $3,338,371 | dollars as filed | |
| PROCORE TECHNOLOGIES INC COM | 74275K108 | Stock | 64,030 | $3,311,632 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 3,154,076 | $3,280,239 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 23,003 | $3,172,804 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 735,000 | $3,057,600 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 781,722 | $3,001,812 | dollars as filed | |
| STARWOOD PPTY TR INC COM | 85571B105 | REIT | 196,355 | $2,650,793 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 1,000,000 | $2,330,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 100,000 | $2,059,000 | dollars as filed | |
| NETSKOPE INC CL A | 64119N608 | COMMON STOCK | 97,148 | $1,694,261 | dollars as filed | |
| SERVICETITAN INC SHS CL A | 81764X103 | Stock | 25,360 | $1,668,434 | dollars as filed | |
| FIRST ADVANTAGE CORP NEW | 31846B108 | COM | 88,665 | $1,578,237 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 566,509 | $1,433,268 | dollars as filed | |
| WW INTL INC | 98262P200 | COM NEW | 71,277 | $1,101,942 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 733,568 | $894,953 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W901 | CALL | 800,000 | $888,000 | dollars as filed | call |
| STABLECOINX INC | 85238K118 | *W EXP 06/25/203 | 167,795 | $838,975 | dollars as filed | |
| MARKER THERAPEUTICS INC | 57055L206 | COM NEW | 554,250 | $593,048 | dollars as filed | |
| FOLD HLDGS INC | 29103K100 | COM CL A | 856,632 | $454,015 | dollars as filed | |
| NIOCORP DEVS LTD | 654484153 | *W EXP 03/17/202 | 268,280 | $201,210 | dollars as filed | |
| SAGIMET BIOSCIENCES INC | 786700904 | COM SER A | 365,400 | $200,970 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686J906 | CALL | 300,000 | $181,000 | dollars as filed | call |
| PIPER SANDLER COMPANIES | 724078209 | COM NEW | 2,428 | $160,175 | dollars as filed | |
| CARIS LIFE SCIENCES INC | 142152107 | COMMON STOCK | 4,711 | $144,298 | dollars as filed | |
| REZOLVE AI PLC | G75398118 | *W EXP 08/15/202 | 235,121 | $129,317 | dollars as filed | |
| ENERGY TRANSFER L P | 29273V100 | COM UT LTD PTN | 5,326 | $105,295 | dollars as filed | |
| Engene Therapeutics Inc W Exp 10/31/202 | 29286X119 | SPAC Combination | 511,177 | $102,287 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617K901 | COM | 200,000 | $100,000 | dollars as filed | call |
| VODAFONE GROUP PLC SPONSORED ADR | 92857W308 | ADR | 5,371 | $86,769 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B904 | COM | 619,700 | $48,773 | dollars as filed | call |
| Brand Engagement Network Inc W Exp 03/14/202 | 104932116 | SPAC Combination | 746,953 | $37,348 | dollars as filed | |
| Alpha Modus Hldgs Inc W Exp 12/13/202 | 020952115 | SPAC Combination | 1,854,665 | $37,093 | dollars as filed | |
| TACTICAL RES CORP COMMON SHARES | 87356V306 | Stock | 11,250 | $29,882 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 2,392 | $28,537 | dollars as filed | |
| Dave Inc W Exp 01/05/202 | 23834J110 | SPAC Combination | 28,750 | $28,175 | dollars as filed | |
| Roadzen Inc W Exp 11/30/202 | G7606H116 | SPAC Combination | 225,000 | $22,500 | dollars as filed | |
| Southland Hldgs Inc W Exp 02/14/202 | 84445C118 | SPAC Combination | 860,302 | $17,206 | dollars as filed | |
| Livewire Group Inc W Exp 09/26/202 | 53838J113 | SPAC Combination | 400,000 | $16,000 | dollars as filed | |
| ALPHA MODUS HLDGS INC | 020952206 | COM | 9,853 | $15,272 | dollars as filed | |
| AEON BIOPHARMA INC | 00791X209 | COM | 42,353 | $12,706 | dollars as filed | |
| TEVOGEN BIO HLDGS INC | 88165K119 | *W EXP 02/14/202 | 200,000 | $12,000 | dollars as filed | |
| ERASCA INC | 29479A908 | CALL | 100,000 | $10,000 | dollars as filed | call |
| SHF Holdings Inc | 824430409 | COM | 6,324 | $9,296 | dollars as filed | |
| BLUE GOLD LTD | G1331C112 | *W EXP 04/01/203 | 175,000 | $7,000 | dollars as filed | |
| Zeo Energy Corp W Exp 03/13/202 | 98944F117 | SPAC Combination | 250,000 | $5,000 | dollars as filed | |
| Nvni Group Limited W Exp 11/01/202 | G50716110 | SPAC Combination | 200,000 | $4,000 | dollars as filed | |
| KATAPULT HOLDINGS INC | 485859201 | COM NEW | 5,421 | $3,547 | dollars as filed | |
| BAIRD MED INVT HLDGS LTD | G0705H111 | *W EXP 10/01/202 | 100,000 | $3,000 | dollars as filed | |
| Liminatus Pharma Inc. W Exp 04/30/203 | 53271X116 | SPAC Combination | 50,000 | $2,000 | dollars as filed | |
| Xbp Global Holdings Inc W Exp 11/30/202 | 98400V119 | SPAC Combination | 24,778 | $1,239 | dollars as filed | |
| Stardust Pwr Inc W Exp 06/21/202 | 854936119 | SPAC Combination | 16,666 | $1,167 | dollars as filed | |
| ASPIRE BIOPHARMA HLDGS INC | 738920115 | *W EXP 02/14/203 | 50,000 | $500 | dollars as filed | |
| PAGAYA TECHNOLOGIES LTD | M7S64L107 | WTS | 48,661 | $487 | dollars as filed | |
| WALDENCAST PLC | G9503X111 | *W EXP 07/27/202 | 33,333 | $333 | dollars as filed | |
| Cid Holdco Inc W Exp 12/31/202 | 171756117 | SPAC Combination | 444,515 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-459653 | this filing | 2026-11-13 |